Literature DB >> 7628545

Protein-protein interactions between human nuclear lamins expressed in yeast.

Q Ye1, H J Worman.   

Abstract

Protein-protein interactions between the nuclear lamins are responsible for the assembly of the nuclear lamina, a meshwork of intermediate filaments associated with the nuclear envelope inner membrane. We have used the yeast two-hybrid system to examine the interactions between the predominant human nuclear lamins expressed as GAL4 fusion proteins in Saccharomyces cerevisiae. Lamin A, prelamin A, lamin B1, and lamin C were able to form homodimers as well as heterodimers. Analysis of the different structural domains of lamin B1 demonstrated that the second half of coil 2 of the rod domain was necessary for the formation of the most stable homodimers. The results show that the yeast two-hybrid system can be used to study the interactions between structural proteins and their domains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628545     DOI: 10.1006/excr.1995.1230

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

1.  Meiotic lamin C2: the unique amino-terminal hexapeptide GNAEGR is essential for nuclear envelope association.

Authors:  M Alsheimer; E von Glasenapp; M Schnolzer; H Heid; R Benavente
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Amino acid substitutions of coiled-coil protein Tpr abrogate anchorage to the nuclear pore complex but not parallel, in-register homodimerization.

Authors:  M E Hase; N V Kuznetsov; V C Cordes
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

Review 3.  The nucleoskeleton as a genome-associated dynamic 'network of networks'.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-05       Impact factor: 94.444

4.  Lamin A/C-dependent localization of Nesprin-2, a giant scaffolder at the nuclear envelope.

Authors:  Thorsten Libotte; Hafida Zaim; Sabu Abraham; V C Padmakumar; Maria Schneider; Wenshu Lu; Martina Munck; Christopher Hutchison; Manfred Wehnert; Birthe Fahrenkrog; Ursula Sauder; Ueli Aebi; Angelika A Noegel; Iakowos Karakesisoglou
Journal:  Mol Biol Cell       Date:  2005-04-20       Impact factor: 4.138

Review 5.  Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin.

Authors:  Thomas Dechat; Katrin Pfleghaar; Kaushik Sengupta; Takeshi Shimi; Dale K Shumaker; Liliana Solimando; Robert D Goldman
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

6.  Dynamic properties of meiosis-specific lamin C2 and its impact on nuclear envelope integrity.

Authors:  Daniel Jahn; Sabine Schramm; Ricardo Benavente; Manfred Alsheimer
Journal:  Nucleus       Date:  2010-03-15       Impact factor: 4.197

7.  Screening and identification of proteins interacting with nucleostemin.

Authors:  Hai-Xia Yang; Geng-Lin Jin; Ling Meng; Jian-Zhi Zhang; Wen-Bin Liu; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

8.  Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.

Authors:  Frederic F Depreux; Megan J Puckelwartz; Aleksandra Augustynowicz; Don Wolfgeher; Christine M Labno; Dynora Pierre-Louis; Danielle Cicka; Stephen J Kron; James Holaska; Elizabeth M McNally
Journal:  Hum Mol Genet       Date:  2015-05-06       Impact factor: 6.150

9.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.

Authors:  Taegun Seo; Daeyoup Lee; Young Sam Shim; Jon E Angell; Natesa V Chidambaram; Dhananjaya V Kalvakolanu; Joonho Choe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  Partners and post-translational modifications of nuclear lamins.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Chromosoma       Date:  2013-03-12       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.